The objective of this program is to conduct basic and clinical research on the problems of childhood cancer that will lead to new insights of the biology of cancer and more effective treatment. Since opening its doors in 1962, this program has provided care for over 10,000 children with cancer. Virtually every patient is treated according to a research protocol in order to provide the best contemporary care, opportunities for improvement of treatment regimens and the necessary data for development of new knowledge concerning clinical aspects of childhood cancer. St. Jude has five departments of basic laboratory research: Virology/Molecular Biology, Biochemistry, Biochemical and Clinical Pharmacology, Immunology, and Tumor Cell Biology. All are engaged in an extensive network of collaborative research involving both clinical and basic cancer center investigators. To enable us to expand our studies further into the etiology of childhood cancer, the Board of Governors has authorized the establishment of a new Department of Genetics. The CORE grant provides support which enables us to accomplish our objectives within the unique capabilities of St. Jude Children's Research Hospital, the only NCI-sponsored cancer center devoted solely to cancer in children.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA021765-16
Application #
3101655
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1977-09-01
Project End
1995-02-28
Budget Start
1993-03-01
Budget End
1994-02-28
Support Year
16
Fiscal Year
1993
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Zheng, Daniel J; Krull, Kevin R; Chen, Yan et al. (2018) Long-term psychological and educational outcomes for survivors of neuroblastoma: A report from the Childhood Cancer Survivor Study. Cancer 124:3220-3230
Fatima, Soghra; Zhou, Sheng; Sorrentino, Brian P (2018) Marking of definitive HSC precursors in E7.5-E8.5 embryos using an Abcg2-CreER lineage-tracing mouse model. Exp Hematol 65:29-33
Chen, Wenan; Li, Yan; Easton, John et al. (2018) UMI-count modeling and differential expression analysis for single-cell RNA sequencing. Genome Biol 19:70
Snaman, J M; Talleur, A C; Lu, J et al. (2018) Treatment intensity and symptom burden in hospitalized adolescent and young adult hematopoietic cell transplant recipients at the end of life. Bone Marrow Transplant 53:84-90
Robinson, Giles W; Rudneva, Vasilisa A; Buchhalter, Ivo et al. (2018) Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial. Lancet Oncol 19:768-784
Creutzig, Ursula; Kutny, Matthew A; Barr, Ronald et al. (2018) Acute myelogenous leukemia in adolescents and young adults. Pediatr Blood Cancer 65:e27089
Gilleland Marchak, Jordan; Seidel, Kristy D; Mertens, Ann C et al. (2018) Perceptions of risk of infertility among male survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Cancer 124:2447-2455
Inaba, Hiroto; Cao, Xueyuan; Han, Alice Q et al. (2018) Bone mineral density in children with acute lymphoblastic leukemia. Cancer 124:1025-1035
Wilson, Carmen L; Howell, Carrie R; Partin, Robyn E et al. (2018) Influence of fitness on health status among survivors of acute lymphoblastic leukemia. Pediatr Blood Cancer 65:e27286
Mueller, Emily L; Park, Elyse R; Kirchhoff, Anne C et al. (2018) Insurance, chronic health conditions, and utilization of primary and specialty outpatient services: a Childhood Cancer Survivor Study report. J Cancer Surviv 12:639-646

Showing the most recent 10 out of 6764 publications